Nearly half of advanced ovarian cancer patients relapsed after first-line PARP inhibitor maintenance, emphasizing the need for refined postrecurrence strategies. BRCA mutation carriers were more ...

A groundbreaking new study provides the first consistent global picture of glacier decline since 2000, revealing that glaciers across the world have lost a whopping 5% of their volume since then. When ...

For years, anxiety about battery wear has shadowed the rise of electric vehicles, shaping everything from resale values to fleet purchasing decisions. A new large-scale study of 22,700 cars now offers ...

Mepolizumab significantly reduced asthma exacerbations and oral corticosteroid use in patients with SEA, with or without CRSwNP, in a real-world setting. Improvements in lung function and asthma ...

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...

Nearly half of the world's population could be living under conditions of extreme heat by the middle of this century if ...

Patients dropped fewer pounds during real-world use compared to the amount lost in clinical trials Getty A new study analyzed patients who used GLP-1 medications in a real-world setting Researchers ...

In one of the first real-world studies, Tirzepatide shows impressive weight loss results for people without diabetes—shedding nearly 13% of body weight in just six months. Study: Real-world use and ...